Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Schito

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Antibiotics (Basel, Switzerland)|March 29, 2023
Efficacy of Cefoperazone Sulbactam in Patients with <i>Acinetobacter</i> Infections: A Systematic Review of the LiteratureGowthami Sai Kogilathota Jagirdhar, Kaanthi Rama, Shiva Teja Reddy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 19, 2019
Building the Framework for Standardized Clinical Laboratory Reporting of Next-generation Sequencing Data for Resistance-associated Mutations in Mycobacterium tuberculosis ComplexJeffrey A Tornheim, Angela M Starks, Timothy C Rodwell, et al.
The Journal of Infectious Diseases|March 10, 2012
Perspectives on introduction and implementation of new point-of-care diagnostic testsKara M Palamountain, Jeff Baker, Elliot P Cowan, et al.
The Journal of Infectious Diseases|March 14, 2015
Defining the needs for next generation assays for tuberculosisClaudia M Denkinger, Sandra V Kik, Daniela Maria Cirillo, et al.
The Lancet. Infectious Diseases|April 3, 2016
Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkersRobert S Wallis, Markus Maeurer, Peter Mwaba, et al.
The Lancet. Infectious Diseases|March 28, 2014
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospectsAlimuddin I Zumla, Stephen H Gillespie, Michael Hoelscher, et al.
Critical Care Explorations|April 7, 2023
A Path to Real-World Evidence in Critical Care Using Open-Source Data Harmonization ToolsSmith F Heavner, Wesley Anderson, Rahul Kashyap, et al.
Journal of Immunological Methods|January 23, 2014
Development of a contemporary globally diverse HIV viral panel by the EQAPOL programAna M Sanchez, C Todd DeMarco, Bhavna Hora, et al.
The Journal of Infectious Diseases|March 14, 2015
Target product profile of a molecular drug-susceptibility test for use in microscopy centersClaudia M Denkinger, David Dolinger, Marco Schito, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data PlatformAngela M Starks, Enrique Avilés, Daniela M Cirillo, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Antibiotics (Basel, Switzerland)|March 29, 2023
Efficacy of Cefoperazone Sulbactam in Patients with <i>Acinetobacter</i> Infections: A Systematic Review of the LiteratureGowthami Sai Kogilathota Jagirdhar, Kaanthi Rama, Shiva Teja Reddy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 19, 2019
Building the Framework for Standardized Clinical Laboratory Reporting of Next-generation Sequencing Data for Resistance-associated Mutations in Mycobacterium tuberculosis ComplexJeffrey A Tornheim, Angela M Starks, Timothy C Rodwell, et al.
The Journal of Infectious Diseases|March 10, 2012
Perspectives on introduction and implementation of new point-of-care diagnostic testsKara M Palamountain, Jeff Baker, Elliot P Cowan, et al.
The Journal of Infectious Diseases|March 14, 2015
Defining the needs for next generation assays for tuberculosisClaudia M Denkinger, Sandra V Kik, Daniela Maria Cirillo, et al.
The Lancet. Infectious Diseases|April 3, 2016
Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkersRobert S Wallis, Markus Maeurer, Peter Mwaba, et al.
The Lancet. Infectious Diseases|March 28, 2014
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospectsAlimuddin I Zumla, Stephen H Gillespie, Michael Hoelscher, et al.
Critical Care Explorations|April 7, 2023
A Path to Real-World Evidence in Critical Care Using Open-Source Data Harmonization ToolsSmith F Heavner, Wesley Anderson, Rahul Kashyap, et al.
Journal of Immunological Methods|January 23, 2014
Development of a contemporary globally diverse HIV viral panel by the EQAPOL programAna M Sanchez, C Todd DeMarco, Bhavna Hora, et al.
The Journal of Infectious Diseases|March 14, 2015
Target product profile of a molecular drug-susceptibility test for use in microscopy centersClaudia M Denkinger, David Dolinger, Marco Schito, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data PlatformAngela M Starks, Enrique Avilés, Daniela M Cirillo, et al.
Pageof 6